Voyager Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -74.9% | -74.9% | -36.7% |
| FY2022 | -78.6% | -78.6% | -29.1% |
| FY2023 | 56.0% | 56.0% | 37.7% |
| FY2024 | -21.7% | -21.7% | -16.5% |
| FY2025 | -61.1% | -61.1% | -47.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -74.9% | -74.9% | -36.7% |
| FY2022 | -78.6% | -78.6% | -29.1% |
| FY2023 | 56.0% | 56.0% | 37.7% |
| FY2024 | -21.7% | -21.7% | -16.5% |
| FY2025 | -61.1% | -61.1% | -47.5% |